“Waiting for DAAs”: A retrospective chart review of patients with untreated hepatitis C in Rwanda

BACKGROUND: Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. With the advent of direct acting antivirals (DAAs), highly effective and easy-to-deliver oral regimens are now available on the global market. This study was conducted to understand the background...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Gupta, Neil, Kabahizi, Jules, Mukabatsinda, Constance, Walker, Timothy David, Musabeyezu, Emmanuel, Kiromera, Athanase, Van Nuil, Jennifer Ilo, Steiner, Kevin, Mukherjee, Joia, Nsanzimana, Sabin, Mbituyumuremyi, Aimable
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5360324/
https://ncbi.nlm.nih.gov/pubmed/28323868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0174148
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires